184 related articles for article (PubMed ID: 4350521)
1. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
Feorino PM; Palmer EL
J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
[No Abstract] [Full Text] [Related]
2. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
Janda Z; Kanka J; Vonka V; Svoboda B
Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
[No Abstract] [Full Text] [Related]
3. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
McDonald AD; Williams MC; Manfreda J; West R
Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
[No Abstract] [Full Text] [Related]
4. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
Kawana T; Yoshino K; Kasamatsu T
Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
[No Abstract] [Full Text] [Related]
5. Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls.
Pacsa AS; Kummerländer L; Pejtsik B; Pali K
J Natl Cancer Inst; 1975 Oct; 55(4):775-81. PubMed ID: 171424
[TBL] [Abstract][Full Text] [Related]
6. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
Aurelian L
Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156
[No Abstract] [Full Text] [Related]
7. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
Aurelian L
Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067
[No Abstract] [Full Text] [Related]
8. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
9. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
Ito H; Kurihara S; Nishimura C
Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
[No Abstract] [Full Text] [Related]
10. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
[No Abstract] [Full Text] [Related]
11. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
Rawls WE; Adam E; Melnick JL
Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
[No Abstract] [Full Text] [Related]
12. Relation of type 2 Herpesvirus antibodies to cervical neoplasia. Barbados, West Indies, 1971.
Ory H; Conger B; Richart R; Barron B
Obstet Gynecol; 1974 Jun; 43(6):901-4. PubMed ID: 4364212
[No Abstract] [Full Text] [Related]
13. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
[No Abstract] [Full Text] [Related]
14. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
Aurelian L; Cornish JD; Smith MF
IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
[No Abstract] [Full Text] [Related]
15. Relationship of herpes simplex virus type-2 antibodies and squamous dysplasia to cervical carcinoma in situ.
Thomas DB; Rawls WE
Cancer; 1978 Dec; 42(6):2716-25. PubMed ID: 215294
[TBL] [Abstract][Full Text] [Related]
16. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique.
Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T
Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
Chiphangwi JD
IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
[TBL] [Abstract][Full Text] [Related]
19. Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.
Najem SN; Barton IG; Al-Omar LS; Potter CW
Br J Exp Pathol; 1982 Oct; 63(5):485-9. PubMed ID: 6293526
[TBL] [Abstract][Full Text] [Related]
20. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
Tarro G; Sabin AB
Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
